MedTrace Logo

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

NCT05984667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2026-02-20

No results posted yet for this study

Summary

The goal of Phase Ib Trial is to determine the feasibility and acceptability of telehealth C-SMART for patients with primary brain tumor and mild neurocognitive deficits (N=18) and their caregivers (N=14) A subset (n=3) of participants will undergo rs-fMRI both pre- and post-C-SMART to test feasibility of advanced functional imaging in this population.

Conditions

  • Glioma, Mixed
  • Mild Neurocognitive Disorder
  • Brain Tumor

Interventions

BEHAVIORAL

C-SMART

The C-SMART intervention includes approximately 8 individual therapy sessions, each approximately 60 minutes in length, delivered weekly. C-SMART intervention components include cognitive rehabilitation and mindfulness training.

Sponsors & Collaborators

  • American Psychological Foundation

    collaborator OTHER

  • American Cancer Society, Inc.

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Sarah E Braun, PhD · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2025-07-23
Completion
2025-07-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05984667 on ClinicalTrials.gov